International Market

GAP distributes a large number of generic products to markets outside of Greece, such as those of Europe, America, Canada, Middle East, Far East and Africa through a well-organised network of representatives or client companies.

In addition to the products available in the Greek market, GAP has developed products that meet the demands of international markets e.g. Co-Artemax, an anti-malarial drug etc.

Moreover, GAP continues investing in soft capsule technology and keeps developing pharmaceutical products, generic and inovative, with a goal to further expand into International markets.